Gardasil was fast-tracked to licensure by the U.S. Food and Drug Administration (FDA) in 2006 and first recommended by the U.S. Centers for Disease Control and Prevention (CDC) to be given to all 11-12-year-old girls. It was known at the time that Merck used an aluminum containing bioactive “placebo” in pre-licensure trials and only tested the vaccine in a small number of children under age 15.
> Gardasil was fast-tracked to licensure by the U.S. Food and Drug Administration (FDA) in 2006 and first recommended by the U.S. Centers for Disease Control and Prevention (CDC) to be given to all 11-12-year-old girls. It was known at the time that Merck used an aluminum containing bioactive “placebo” in pre-licensure trials and only tested the vaccine in a small number of children under age 15.
Login or register